retatrutide cardiovascular side effects What are reported with Retatrutide? retatrutide cardiac side effects 💉𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲'𝘀

doi:10.1016/j.eclinm.2025.103363

Ensure the injection site is clean

Freischmidt, A

Its discovery in 1992 paved the way for exenatide, the first GLP-1 receptor agonist approved for diabetes in 2005

Duration Guidelines Based on Clinical Evidence Current medical guidelines recommend continuing GLP-1 therapy indefinitely for patients with obesity or weight-related metabolic conditions, similar to how blood pressure or cholesterol medications are managed long-term

Surjanhata BC, Moshiree B, Lee AA et al (2025) Impact of constipation therapies on severity of gastroparesis and constipation symptoms in relation to gastric and colonic transit